Related Experiment Video
Updated: Feb 14, 2026

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
Published on: March 24, 2017
Identification and characterization of neutralization epitopes at VP2 and VP1 of enterovirus A71
Nmn NikNadia1, Chee Wah Tan1, Kien Chai Ong2
1Faculty of Medicine, Department of Medical Microbiology, University of Malaya, Kuala Lumpur, Malaysia.
Abstract:
Enterovirus A71 (EV-A71) neutralization escape mutants were generated with monoclonal antibody MAB979 (Millipore). The VP2-T141I and VP1-D14N substitutions were identified. Using reverse genetics, infectious clones with these substitutions were constructed and tested by neutralization assay with immune sera from mice and humans. The N-terminus VP1-14 is more important than EF loop VP2-141 in acute human infection, mainly because it recognised IgM present in acute infection. The N-terminus VP1 could be a useful target for diagnostics and therapeutic antibodies in acute infection.
Insights
Enterovirus A71 (EV-A71) escape mutants revealed VP1-14 as crucial for acute human infection, particularly its recognition of IgM. This N-terminus VP1 region shows promise for developing diagnostics and therapeutics against EV-A71.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Enterovirus A71 (EV-A71) is a significant human pathogen causing hand, foot, and mouth disease and severe neurological complications.
- Neutralizing antibodies are critical for controlling EV-A71 infections, but the virus can evolve escape mutants.
- Understanding the mechanisms of EV-A71 immune escape is essential for developing effective vaccines and therapies.
Purpose of the Study:
- To identify and characterize EV-A71 neutralization escape mutants generated against a specific monoclonal antibody.
- To investigate the functional significance of identified mutations in viral neutralization and infectivity.
- To evaluate the potential of viral epitopes as targets for diagnostics and therapeutics.
Main Methods:
- Generation of EV-A71 neutralization escape mutants using monoclonal antibody MAB979.
- Identification of amino acid substitutions in viral proteins (VP2 and VP1) through sequencing.
- Construction of infectious EV-A71 clones harboring specific mutations using reverse genetics.
- Neutralization assays using immune sera from infected mice and humans.
Main Results:
- Two key substitutions, VP2-T141I and VP1-D14N, were identified in escape mutants.
- The VP1-D14N substitution at the VP1 N-terminus was found to be more critical for neutralization escape in acute human infection compared to VP2-T141I.
- The VP1 N-terminus demonstrated significant recognition of IgM antibodies present during acute infection.
Conclusions:
- The N-terminus of EV-A71 VP1 is a critical determinant for neutralization escape, particularly due to its interaction with IgM during acute infection.
- The identified VP1 N-terminus epitope represents a promising target for the development of novel diagnostics and therapeutic antibodies against EV-A71.
- Further research into VP1 N-terminus-targeting strategies could lead to improved control of EV-A71 outbreaks.
More Related Videos
05:15Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
Published on: February 10, 2022
13:41Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Related Concept Videos
Acids, Bases and Neutralization Reactions
Acids, Bases and Neutralization Reactions
Bending of Curved Members - Neutral Surface
Consider the curved member described in the previous lesson. According to Hooke's law, which relates stress to strain within the...
Unsymmetric Bending - Angle of Neutral Axis
When a bending moment is applied at an angle θ concerning the vertical axis of a symmetrical member, it can be resolved into components along the member's principal...
Methods of Classification and Identification
Pharmacogenomics: Identification of New Drug Targets